These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28073210)

  • 21. Effect of alkalinization on calcium oxalate monohydrate calculi during extracorporeal shock wave lithotripsy: in vivo experiments.
    Vandeursen H; De Ridder D; Demeulenaere R; Pittomvils G; Boving R; Baert L
    Urol Int; 1992; 48(2):203-5. PubMed ID: 1316663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment.
    Caudarella R; Vescini F
    Arch Ital Urol Androl; 2009 Sep; 81(3):182-7. PubMed ID: 19911682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Citrate and renal stones].
    del Valle EE; Spivacow FR; Negri AL
    Medicina (B Aires); 2013; 73(4):363-8. PubMed ID: 23924538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lemonade therapy increases urinary citrate and urine volumes in patients with recurrent calcium oxalate stone formation.
    Penniston KL; Steele TH; Nakada SY
    Urology; 2007 Nov; 70(5):856-60. PubMed ID: 17919696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potassium-sodium citrate prevents the development of renal microcalculi into symptomatic stones in calcium stone-forming patients.
    Unno R; Taguchi K; Okada A; Ando R; Hamamoto S; Kubota Y; Zuo L; Tozawa K; Kohri K; Yasui T
    Int J Urol; 2017 Jan; 24(1):75-81. PubMed ID: 27747937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stone size limits the use of Hounsfield units for prediction of calcium oxalate stone composition.
    Stewart G; Johnson L; Ganesh H; Davenport D; Smelser W; Crispen P; Venkatesh R
    Urology; 2015 Feb; 85(2):292-5. PubMed ID: 25481232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stone clearance after extracorporeal shockwave lithotripsy in patients with solitary pure calcium oxalate stones smaller than 1.0 cm in the proximal ureter, with special reference to monohydrate and dihydrate content.
    Ichiyanagi O; Nagaoka A; Izumi T; Kawamura Y; Tsukigi M; Ishii T; Ohji H; Kato T; Tomita Y
    Scand J Urol; 2013 Apr; 47(2):131-9. PubMed ID: 22870910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of citrate on the different phases of calcium oxalate crystallization.
    Tiselius HG; Berg C; Fornander AM; Nilsson MA
    Scanning Microsc; 1993 Mar; 7(1):381-9; discussion 389-90. PubMed ID: 8316807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
    J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The composition and quantitative analysis of urinary calculi in patients with renal calculi.
    Jawalekar S; Surve VT; Bhutey AK
    Nepal Med Coll J; 2010 Sep; 12(3):145-8. PubMed ID: 21446361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.
    Pak CY; Heller HJ; Pearle MS; Odvina CV; Poindexter JR; Peterson RD
    J Urol; 2003 Feb; 169(2):465-9. PubMed ID: 12544288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of sodium citrate, potassium citrate, and citric acid in preventing experimental calcium oxalate urolithiasis in rats.
    Ogawa Y; Tanaka T; Yamaguchi K; Morozumi M; Kitagawa R
    Hinyokika Kiyo; 1987 Nov; 33(11):1772-7. PubMed ID: 3445859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of urinary oxalate by combined calcium and citrate administration without increase in urinary calcium oxalate stone formers.
    Ito H; Suzuki F; Yamaguchi K; Nishikawa Y; Kotake T
    Clin Nephrol; 1992 Jan; 37(1):14-8. PubMed ID: 1541059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Risk factors for the formation of urinary calcium-containing stones in diabetics].
    Liu JG; Hu M; He XQ
    Zhonghua Nei Ke Za Zhi; 1989 Nov; 28(11):649-53, 699-700. PubMed ID: 2632175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythrocyte oxidative stress in patients with calcium oxalate stones correlates with stone size and renal tubular damage.
    Ma MC; Chen YS; Huang HS
    Urology; 2014 Feb; 83(2):510.e9-17. PubMed ID: 24360074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of trends in urolith composition in cats: 5,230 cases (1985-2004).
    Cannon AB; Westropp JL; Ruby AL; Kass PH
    J Am Vet Med Assoc; 2007 Aug; 231(4):570-6. PubMed ID: 17696857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spectrum of stone composition: structural analysis of 1050 upper urinary tract calculi from northern India.
    Ansari MS; Gupta NP; Hemal AK; Dogra PN; Seth A; Aron M; Singh TP
    Int J Urol; 2005 Jan; 12(1):12-6. PubMed ID: 15661049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Two cases of uric acid stones unsuccessfully dissociated by oral chemolysis].
    Funahashi M; Yamada T; Murayama T
    Hinyokika Kiyo; 2006 Jan; 52(1):47-8. PubMed ID: 16479990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Citrate (CG-120) therapy in urolithiasis. 2. Effect on urinary and serum biochemistry ].
    Ohkawa T; Ebisuno S; Morimoto S; Yasukawa S; Sonoda T; Koide T; Oka T; Aso Y; Higashihara E; Kitagawa R
    Hinyokika Kiyo; 1988 May; 34(5):918-31. PubMed ID: 3051946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.